![Daniël Jan Ellens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniël Jan Ellens
President chez
Elkerim GmbH
Profil
Daan Ellens serves on the supervisory board of Zealand (DK).
He was, until recently, chief executive officer of Rhein Biotech, a global biotechnology group, which develops, produces and markets vaccines and therapeutic compounds based on its platform technologies.
As the CEO, Dr. Ellens restructured Rhein Biotech from a German contract research organization into a rapidly growing worldwide operating biotech group, listed at the Neuer Markt in Frankfurt .
In 2002, he merged Rhein Biotech with Berna, based in Switzerland , thus positioning the combined entity as the world’s number one pure-play vaccine company.
He was instrumental in developing the company until where it is today.
Daan Ellens received his PhD in Molecular Biology of the University Utrecht in 1974 and an MBA degree from the Technical University Eindhoven and the University of Tilburg in1992.
Daan’s extensive and successful track record as one of the most successful European biotech entrepreneurs adds significant value to the LSP team and investment process.
Dr. Ellens is venture partner at Life Sciences Partners, Amsterdam.
Postes actifs de Daniël Jan Ellens
| Sociétés | Poste | Début |
|---|---|---|
Elkerim GmbH
 Elkerim GmbH Real Estate DevelopmentFinance Provides biotechnology, art and real estate advisory & brokerage and financing services | President | 02/12/2010 |
Anciens postes connus de Daniël Jan Ellens
| Sociétés | Poste | Fin |
|---|---|---|
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Private Equity Investor | 31/03/2015 |
Rhein Biotech NV
 Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical drugs and vaccines | Président | - |
Janssen Vaccines Corp.
 Janssen Vaccines Corp. Pharmaceuticals: MajorHealth Technology Manufactures finished medicaments | Président | 01/01/2006 |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Produces and develops immunobiological preparations | Directeur des opérations | 01/12/2004 |
Janssen Vaccines Corp.
Janssen Vaccines Corp. Pharmaceuticals: MajorHealth Technology Manufactures finished medicaments | Directeur des opérations | 01/12/2001 |
Formation de Daniël Jan Ellens
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Berna Biotech AG
Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Produces and develops immunobiological preparations | Commercial Services |
Rhein Biotech NV
Rhein Biotech NV Miscellaneous Commercial ServicesCommercial Services Develops and manufactures pharmaceutical drugs and vaccines | Commercial Services |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
Janssen Vaccines Corp.
Janssen Vaccines Corp. Pharmaceuticals: MajorHealth Technology Manufactures finished medicaments | Health Technology |
Hybrigenics SA
 Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Technische Universiteit Eindhoven
 Technische Universiteit Eindhoven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Kreatech Biotechnology BV
 Kreatech Biotechnology BV Medical/Nursing ServicesHealth Services Provides diagnostics detection products | Health Services |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Kreatech Holding BV
 Kreatech Holding BV Medical/Nursing ServicesHealth Services Operates as a holding company with interest in the development and commercialization of detection products | Health Services |
Elkerim GmbH
Elkerim GmbH Real Estate DevelopmentFinance Provides biotechnology, art and real estate advisory & brokerage and financing services | Finance |
Choisissez Zonebourse 
